ERBB2 and invasive ductal breast carcinoma: A needle biopsy revealed invasive ductal carcinoma of the breast, characterized by estrogen receptor (ER) positivity at 60%, progesterone receptor (PR) positivity at 40%, human epidermal growth factor receptor 2 (HER2) negativity at 0%, and a Ki-67 index of 8%.